How many insider trades does FilingIQ track for ZNTL?

FilingIQ tracks 563 Form 4 insider transactions for ZNTL (Zentalis Pharmaceuticals, Inc.), covering filings from Apr 7, 2020 onwards. 0 of those were filed in the last 90 days.

Are ZNTL insiders net buyers or net sellers?

Across the full Form 4 history for ZNTL, 16 transactions (3%) were open-market purchases and 451 (80%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ZNTL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ZNTL in?

Zentalis Pharmaceuticals, Inc. (ZNTL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $153.14M.

ZNTL insider trading

Healthcare

Zentalis Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

563

Last 90 days

Buys / sells

3% / 80%

Market cap

$153.14M

About Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Company website: zentalis.com

ZNTL insider activity at a glance

FilingIQ has scored 563 insider transactions for ZNTL since Apr 7, 2020. The most recent filing in our index is dated Feb 10, 2026.

Across the full history, 16 open-market purchases and 451 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ZNTL insider trades is 58.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ZNTL trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding ZNTL

EVENTIDE ASSET MANAGEMENT, LLC

$175.13M · 2.9% of AUM

Decheng Capital Management III (Cayman), LLC

$42.12M · 14.1% of AUM

Frequently asked

How many insider trades does FilingIQ track for ZNTL?: FilingIQ tracks 563 Form 4 insider transactions for ZNTL (Zentalis Pharmaceuticals, Inc.), covering filings from Apr 7, 2020 onwards. 0 of those were filed in the last 90 days.
Are ZNTL insiders net buyers or net sellers?: Across the full Form 4 history for ZNTL, 16 transactions (3%) were open-market purchases and 451 (80%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ZNTL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ZNTL in?: Zentalis Pharmaceuticals, Inc. (ZNTL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $153.14M.

Methodology & sources

Every ZNTL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.